The rationale for drug combinations in age-related macular degeneration

Retina

Volumn 29, Issue SUPPL. 6, 2009, Pages

  Adamis, Anthony P ^a,b  

^a Jerini Ophthalmic Inc   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Age related macular degeneration; Angiogenesis; Fibrosis; Inflammation; Neuroprotection

Indexed keywords

RAPAMYCIN;

CLINICAL TRIAL; DEATH; DISEASE COURSE; DRUG EFFECT; FIBROSIS; HUMAN; INFLAMMATION; NOTE; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT PLANNING; VISUAL IMPAIRMENT;

ANIMALS; CHOROIDAL NEOVASCULARIZATION; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FIBROSIS; HUMANS; INFLAMMATION; MACULAR DEGENERATION; NEUROPROTECTIVE AGENTS; RETINA;

EID: 68049118574     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181ad2500     Document Type: Note

References (4)

1. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2006;51:137-152. (Pubitemid 43269939)
2. Grossniklaus HE, Miskala PH, Green WR, et al. Histopathological and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: submacular surgery trials report no. 7. Arch Ophthalmol 2005;123:914-921.
3. Caicedo A, Espinosa-Heidmann DG, Pina Y, Hernandez EP, Cousins SW. Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroid nevascularization. Exp Eye Res 2005;81:38-47. (Pubitemid 40840544)
4. Sakurai E, Taguchi H, Anand A, et al. Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 2003;44:2743-2749. (Pubitemid 36618439)